Polysilicon Prices and Stable Chemical Business Shape WACKER’s Expectations for 2013


Munich, Mar 14, 2013

Wacker Chemie AG closed 2012 with lower sales and earnings, as already announced. In its annual report released today, the Munich-based chemical Group recorded sales of €4.63 billion, just under 6 percent below the previous year’s €4.91 billion. The decline was chiefly due to weaker prices for solar-grade silicon and semiconductor wafers. Overall, price effects reduced last year’s Group sales by around €700 million or over 14 percent. 2012’s EBITDA – earnings before interest, taxes, depreciation and amortization – came in at €787 million (2011: €1.1 billion). The corresponding EBITDA margin was 17.0 percent (2011: 22.5 percent). EBITDA dropped 29 percent against 2011 mainly because of excess solar-sector capacity. Solar-silicon prices halved within one year. WACKER’s chemical divisions, conversely, grew their EBITDA by some 15 percent relative to 2011, primarily due to accelerating demand for polymer products. WACKER’s bottom line for 2012 shows net income of €107 million, €249 million lower than a year earlier (€356 million).

During the first two months of 2013, WACKER’s chemical divisions continued to perform soundly, reporting satisfactory demand amid the usual seasonal effects of winter. At its polysilicon division, WACKER is currently selling much higher volumes than expected – with prices currently stable at a low level. At Siltronic, there is no indication yet of any fundamental turnaround. Demand for semiconductor wafers is still weak, and prices are low. In total, WACKER expects 2013’s first-quarter sales to outperform Q4 2012, but to fall short of the 2012 first-quarter figure, since polysilicon prices back then were almost twice as high as today.

For full-year 2013, WACKER forecasts sales at the year-earlier level – providing that no major trade barriers are introduced in the solar industry and that semiconductor demand picks up in the second half. Volumes at every division are expected to grow further. In the chemical divisions, sales and EBITDA are projected to be above 2012. At the same time, the Group anticipates a year-over-year decline in average semiconductor prices. Assuming that polysilicon prices remain at their Q4 2012 level, WACKER expects Group EBITDA in 2013 to be below last year’s figure.

“From today’s perspective, 2013 will not be an easy year for WACKER,” said CEO Rudolf Staudigl in Munich on Thursday. “The semiconductor market is currently moving sideways. Polysilicon prices are low, but have bottomed out. At the same time, demand growth is strong among our solar customers. Capacity utilization at our polysilicon plants is climbing fast. If this trend continues, there will be opportunities for higher prices. Our robust chemical business continues to be a key stabilizing factor for the Group.”

Capital Expenditures

The Group’s capital expenditures grew in 2012, up by almost 12 percent to €1.1 billion (2011: €981 million) – the highest amount in the Group’s history. Funding primarily went toward further capacity expansion for hyperpure polycrystalline silicon.

In Q2 2012, expansion stage 9 at Nünchritz reached its full capacity of 15,000 metric tons per year. Last year, WACKER made good progress with constructing its new polysilicon site at Charleston in the US state of Tennessee. Numerous buildings are ready or are about to be completed. Amid the excess capacities currently facing polysilicon, however, WACKER decided last fall to slow down the pace of this project. Charleston’s production start-up is now planned for mid-2015. With this decision, the chemical Group is aligning capacity growth with market demand and, at the same time, easing the burden on 2013’s cash flow by a euro amount in the triple-digit-million range. Due to the longer timescale, investments in Charleston are expected to climb some 10 percent to around US$2 billion. At the same time, the site’s total capacity will grow at least 10 percent to over 20,000 metric tons per year. WACKER is using the additional time to optimize production facilities and improve manufacturing processes there, so that yields are higher.

WACKER is also expanding its capacities for dispersions and polyvinyl acetate solid resins in Asia and the USA. At Nanjing (China), the Group is building two new production facilities. It is expanding its existing dispersions capacities by adding a new reactor with an annual output of 60,000 metric tons. The new facility is expected to start up in the middle of this year. At Nanjing, WACKER is also building a new plant to produce polyvinyl acetate solid resins, with an annual capacity of 20,000 metric tons. It is scheduled to go into operation by the end of this year. Early February, WACKER started up a new dispersions reactor – with an annual capacity of 40,000 metric tons – at its Ulsan site in South Korea. At its US polymers site in Calvert City, WACKER is also adding 30,000 metric tons. Capital expenditures for all four projects totaled some €40 million in 2012. These projects will strengthen the Munich-based Group's position as the world’s leading manufacturer of polymers for dispersions and gumbase.

Additional funding flowed into expanding capacity at Siltronic Samsung Wafer, WACKER’s Singapore joint venture for making 300 mm wafers for the semiconductor industry, as well as into financing its siloxane joint venture with Dow Corning in China.


At the end of 2012, WACKER had 16,292 employees worldwide, 876 fewer than a year earlier (17,168). The decline stems from structural measures in semiconductors. Last year, Siltronic closed Hikari – its Japanese production site for 200 mm wafers – and stopped producing 150 mm wafers at Portland. At year-end, WACKER’s German sites had 12,635 employees (2011: 12,813) and its international sites 3,657 (2011: 4,355).

Net Cash Flow, Net Financial Liabilities and Equity Ratio

As announced, 2012’s net cash flow was clearly in negative territory due to the high investment levels. It amounted to €–536 million (2011: €–158 million). WACKER financed about one third of its investments from its own cash flow. In addition, it drew on borrowed funds for its strategic investment program. Consequently, net financial liabilities increased, as planned, to €701 million on the reporting date (2011: net financial receivables of €96 million).

WACKER’s total assets rose by €93 million last year. On December 31, 2012, they amounted to €6.3 billion (2011: €6.2 billion). Increases were primarily in property, plant and equipment, in loans to associated companies, and in trade receivables. On the reporting date, Group equity amounted to €2.62 billion (2011: €2.63 billion), yielding an equity ratio of 41.4 percent (2011: 42.2 percent).

Business Divisions

Lagging demand for silicon wafers and lower prices weighed on sales at Siltronic. Sales decreased almost 13 percent to €867.9 million (2011: €992.1 million). Business for 300 mm silicon wafers grew during full-year 2012, but there was a slowdown for 200 mm wafers and, above all, for even smaller diameters. EBITDA of €0.7 million was much lower than a year earlier (2011: €49.2 million). It included non-recurring expenses of around €15 million for closing the 150 mm wafer line at Portland. The EBITDA decline was due mainly to negative price effects and to reduced volumes for smaller-wafer diameters.

In 2012, WACKER SILICONES increased its sales by over 3 percent to €1.65 billion (2011: €1.59 billion). Higher volumes and positive exchange-rate effects offset the price pressure on silicone products. EBITDA also edged up to €189.3 million (2011: €182.9 million), climbing some 4 percent on the year-earlier period. Raw-material and energy costs remained high overall, although pricing factors prevented them from climbing further relative to the previous year. Price pressure, especially on standard products, dampened the division’s earnings performance. Conversely, earnings were supported by the US dollar’s strength compared with a year earlier.

WACKER POLYMERS continued its upward trend in 2012. For the first time ever, its sales surpassed the billion-euro mark. At €1.0 billion (2011: €928.1 million), sales were 8 percent higher than in the previous year. Business was lifted by increased dispersion and polymer-powder volumes, by partially better product prices, and by positive exchange-rate effects. Raw-material costs stayed at the prior-year level. EBITDA grew even more strongly than sales, climbing 32 percent year-over-year to €147.4 million (2011: €111.8 million). This increase stemmed from higher volumes, rationalization, and positive product-mix and exchange-rate effects.

WACKER BIOSOLUTIONS also posted strong sales growth, with sales up 9 percent to €157.6 million (2011: €144.5 million). Higher volumes and positive exchange-rate effects fueled the increase. With the exception of biopharmaceuticals, every business area generated growth. EBITDA advanced strongly, too, climbing 20 percent to €24.5 million (2011: €20.4 million) amid higher volumes and exchange-rate effects.

As expected, WACKER POLYSILICON’s sales declined in 2012, down almost 22 percent to €1.14 billion (2011: €1.45 billion). Although the division grew volumes 20 percent to 38,000 metric tons in 2012, year-over-year sales were lower amid significantly reduced hyperpure-polysilicon prices. This decline was due to the difficult market environment, marked by excess capacity, high inventories and ongoing consolidation. To align production output with customer demand, WACKER POLYSILICON decided – as of the third quarter – to partially curb production and to introduce reduced working hours at some Burghausen facilities. EBITDA dropped 43 percent to €427.5 million (2011: €747.3 million), dampened primarily by significantly lower price levels. EBITDA contained income from terminated supply contracts. Here, the division retained advance payments and received damages totaling €113.1 million.

Proposal on Appropriation of Profits

In accordance with German Commercial Code accounting rules, Wacker Chemie AG posted a retained profit of €654.3 million in 2012. At the Annual Shareholders’ Meeting, the Executive and Supervisory Boards will propose a dividend of 60 cents per share (2011: €2.20). Based on the number of dividend-bearing shares as per December 31, 2012, the cash dividend corresponds to a payout of €29.8 million. The resultant distribution ratio – based on the net income allocable to Wacker Chemie AG shareholders – is 26 percent.


The risks of the economy remaining weak during 2013 are still present. The ongoing sovereign-debt crisis in Europe is weighing on EU economies. WACKER, though, anticipates that economic output in EU countries will not decrease very much further. In line with most economic experts, the Group expects the world economy to expand slightly in 2013. Growth will again be strongest in Asia.

In 2013, WACKER’s polysilicon business will remain difficult. The consolidation process in the industry is not yet over, there is still excess capacity, and polysilicon prices are currently low. Additionally, the market faces the burden of anti-dumping investigations by the European Union and the Chinese Ministry of Commerce. If both sides impose punitive tariffs, the global photovoltaic market could suffer. At WACKER POLYSILICON, sales in 2013 are expected to be below the prior year. Downward pressure is chiefly due to average polysilicon prices being lower than a year earlier. Moreover, salt sales are now reported under “Other” and product responsibility for pyrogenic silicas has been transferred to WACKER SILICONES. These two structural changes will reduce WACKER POLYSILICON’s total sales by some €100 million.

According to market researchers, the semiconductor sector will grow, chiefly in the second half of 2013. The year has started off sluggishly, though. WACKER expects Siltronic’s sales to decline in full-year 2013 amid persistent price pressures. Market expansion will be driven mainly by 300 mm business.

The Group’s chemical divisions offer good prospects for further growth in 2013. Sales at WACKER SILICONES are expected to increase, though the price squeeze on standard products will remain. Additional demand will primarily come from Asia. WACKER POLYMERS is targeting sales growth, too. The regions with the highest sales gains are likely to be China, India and the Americas. In Europe, projections are for only a slight sales increase. WACKER BIOSOLUTIONS also anticipates higher sales in 2013. The division sees its major growth opportunities in Asia, and also in Germany.

Overall, WACKER expects sales in 2013 to be at the prior-year level – providing that trade barriers are not introduced in the solar industry and that semiconductor demand picks up in the second half. WACKER has planned for an average US dollar/euro exchange rate of 1.35 in 2013. EBITDA is likely to be below the prior-year level, primarily due to the lower prices for polysilicon and semiconductor wafers.

WACKER intends to invest some €600 million both in 2013 and 2014, with the focus on completing its Charleston site (Tennessee, USA). Investments are unlikely to be covered fully by the anticipated cash flow from operating activities. Depreciation will amount to around €550 million in 2013 and also in 2014.

“Over the next two years, we will manage capital expenditures dynamically, aligning them with our earnings strength,” said CFO Joachim Rauhut. “Our goal is that financial liabilities do not exceed €1 billion this year.”

WACKER’s Key Figures
2012 2011 Change in %
Results / Return
Sales in € m 4,634.9 4,909.7 -5.6
EBITDA in € m 786.8 1,104.2 -28.7
EBITDA margin % 17.0 22.5 -
EBIT in € m 258.0 603.2 -57.2
EBIT margin % 5.6 12.3 -
Financial result -64.8 -35.8 81.0
Income before taxes 193.2 567.4 -65.9
Net income for the year in € m 106.8 356.1 -70.0
Earnings per share in € 2.27 7.10 -68.0
ROCE in % 5.2 13.9 -
Financial Position/ Cash Flows
Total assets in € m 6,329.9 6,237.0 1.5
Equity in € m 2,617.8 2,629.7 -0.5
Equity ratio in % 41.4 42.2 -
Financial liabilities in € m 1,197.2 777.9 53.9
Net financial liabilities/net financial receivables in € m -700.5 95.7 n.a
Capital expenditures (incl. financial assets) in € m 1,095.4 981.2 11.6
Depreciation (incl. financial assets) in € m 528.8 501.0 5.5
Net cash flow in € m -536.2 -157.7 >100
Research and development
R&D expenses in € m 174.5 172.9 0.9
Personnel expenses in € m 1,205.3 1,282.5 -6.0
Employees (December 31) Number 16,292 17,168 -5.1

This press release contains forward-looking statements based on assumptions and estimates of WACKER’s Executive Board. Although we assume the expectations in these forward-looking statements are realistic, we cannot guarantee they will prove to be correct. The assumptions may harbor risks and uncertainties that may cause the actual figures to differ considerably from the forward-looking statements. Factors that may cause such discrepancies include, among other things, changes in the economic and business environment, variations in exchange and interest rates, the introduction of competing products, lack of acceptance for new products or services, and changes in corporate strategy. WACKER does not plan to update the forward­looking statements, nor does it assume the obligation to do so.


Dr. Rudolf Staudigl

Dr. Rudolf Staudigl

President & CEO

Order photo
Dr. Tobias Ohler

Dr. Tobias Ohler

Member of the Executive Board

Order photo
Dr. Christian Hartel

Dr. Christian Hartel

Member of the Executive Board

Order photo
Auguste Willems

Auguste Willems

Member of the Executive Board

Order photo


contact image

Wacker Chemie AG
Media Relations & Information
Christof Bachmair

Tel. +49 89 6279-1830
Email christof.bachmair@wacker.com

Contact for Analysts and Investors

Wacker Chemie AG
Investor Relations
Joerg Hoffmann

Tel. +49 89 6279-1633
Email joerg.hoffmann@wacker.com